Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | DHCR24 | Q15392 | 8/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28030582 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL28030585 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL23326519 | 0.93 | ALDH1A1 (0.66) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL28001753 | 0.90 | DHCR24 (0.56) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL1446269 | 0.90 | DHCR24 (0.55) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL30778467 | 0.88 | ALDH1A1 (0.56) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL30685282 | 0.88 | ALDH1A1 (0.56) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL30266882 | 0.88 | ALDH1A1 (0.56) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL30875104 | 0.88 | ALDH1A1 (0.58) | ALDH1A1MEN1USP2MAPTALOX15 | |
| SCHEMBL15346215 | 0.86 | ALDH1A1 (0.73) | ALDH1A1MEN1USP2MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-26 | — | — | US | disclosed |
| US-12421472-B2 | Process for producing extracted lipid comprising docosahexaenoic acid | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION - (AU) | 2025-09-23 | — | — | US | disclosed |
| US-20240084214-A1 | LIPID COMPRISING POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2024-03-14 | — | — | US | disclosed |
| US-20230416186-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-12-28 | — | — | US | disclosed |
| CN-117179099-A | Method for removing ginkgolic acid in ginkgo leaf tea | 陕西瑞绿园银杏科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-11834621-B2 | Lipid comprising polyunsaturated fatty acids | Nuseed Global Innovation Ltd. (GB) | 2023-12-05 | — | — | US | disclosed |
| US-20220356414-A1 | PROCESS FOR PRODUCING EXTRACTED LIPID COMPRISING DOCOSAHEXAENOIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2022-11-10 | — | — | US | disclosed |
| US-11306271-B2 | Process for producing extracted lipid comprising docosahexaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2022-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | SCD, ELOVL3, DAGLA | ALDH1A1 4269/4885MEN1 4627/4885USP2 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.